Validation study of hla-b* 13:01 as a biomarker of dapsone hypersensitivity syndrome in leprosy patients in Indonesia
10.1371/journal.pntd.0008746
Saved in:
Main Authors: | Krismawati, H., Irwanto, A., Pongtiku, A., Irwan, I.D., Maladan, Y., Sitanggang, Y.A., Wahyuni, T., Tanjung, R., Sun, Y., Liu, H., Zhang, F., Oktavian, A., Liu, J. |
---|---|
Other Authors: | PHARMACY |
Format: | Article |
Published: |
Public Library of Science
2021
|
Online Access: | https://scholarbank.nus.edu.sg/handle/10635/197436 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
HLA-B*13:01 and the dapsone hypersensitivity syndrome
by: Zhang, F.-R., et al.
Published: (2014) -
Dapsone hypersensitivity syndrome overlaps reversal reaction in leprosy patient
by: Chesia Christiani Liuwan, -, et al.
Published: (2019) -
Incidence of anemia in leprosy patients treated with dapsone
by: S. Puavilai, et al.
Published: (2018) -
HLA Class-II‒Restricted CD8<sup>+</sup> T Cells Contribute to the Promiscuous Immune Response in Dapsone-Hypersensitive Patients
by: Qing Zhao, et al.
Published: (2022) -
HLA and leprosy in Chinese
by: Chan, S.H., et al.
Published: (2016)